ADAM12 is A Potential Therapeutic Target Regulated by Hypomethylation in Triple-Negative Breast Cancer.
Mendaza S, Ulazia-Garmendia A, Monreal-Santesteban I, Córdoba A, Azúa YR, Aguiar B, Beloqui R, Armendáriz P, Arriola M, Martín-Sánchez E, Guerrero-Setas D.
Mendaza S, et al. Among authors: armendariz p.
Int J Mol Sci. 2020 Jan 30;21(3):903. doi: 10.3390/ijms21030903.
Int J Mol Sci. 2020.
PMID: 32019179
Free PMC article.